Forgot your password?
Document Actions
Startups in Uncertain Times, Dec 16 2008
Startups in Uncertain Times
in the startup market from the tech transfer office,
angel investor and venture investor perspectives.
Tuesday, December 16, 2008, 1:00-2:30pm ET (10:00-11:30am PT)
A Free Online Webinar Series Dealing
with New Ideas on the Innovation Economy
For U.S. Venture Investors, Angel Investors,
Corporate Technology Scouts, University Officials,
Government Officials, Entrepreneurs and other Innovation Professionals
BioTechTransferWeek article on this webinar. Click Here.
David Lerner
(Director, New Ventures, Science and Technology Ventures, Columbia University)
Paul Sciabica
(Executive Director, New York Angels)
Matt McCooe
(Chart Venture Partners)
Shalom Leaf
(Law Offices of Shalom Leaf)
_______________________________________________________________
AGENDA:
Among the topics to be covered:
COST: Free, but registration required. Long distance charges from your phone company may apply depending your phone plan.
HOW TO PARTICIPATE?: This webinar is online. You need a computer with web access for the visual and a regular phone line to hear the audio. Q&A is conducted by a chat box to the speakers.
WHO SHOULD PARTICIPATE IN THE WEBINAR?: This webinar is open to the public and anyone interested in the International Innovation Economy is invited to attend, including VCs and angel investors, investment professionals, economic development officers, university economic development officials, startup creation managers and professionals, entrepreneurial researchers and grad students, technology transfer managers and professionals, licensing specialists, business development officers, corporate strategic investors, entrepreneurs-in-residence, university research park managers, and others with an interest in the global innovation economy.
_______________________
David B. Lerner
(Director, New Ventures, Science and Technology Ventures, Columbia University)
Bio
David manages Columbia's portfolio of more than sixty spin-off companies, helps launch approximately ten to twelve new start-ups each year and administrates STV's Seed Fund. Prior to joining Columbia, he spent over a decade founding, operating, and funding companies in the healthcare, internet and media sectors. The venture group he founded has invested in medical devices, video platforms, security software, skill-based gaming and consumer internet. David spearheaded the commercialization of a medical therapy that became the state-of-the-art treatment for lymphedema, a debilitating condition that affects 1% of all Americans. He opened multiple treatment facilities and operated a nationally renowned teaching school, securing affiliations with Massachusetts General, Brigham and Women's Hospital, the Dana Farber Cancer Center, and Memorial Sloan-Kettering Cancer Center. After a strategic merger in 1998, the business was acquired in 2001 by one of the nation's leading providers of physical medicine and rehabilitation services. David's most recent venture was the founding and seed-funding of a video management platform company that secured $6 million in Series A funding and was sold to a publicly held company on the NASDAQ. He currently serves as Board Observer to StackSafe, Inc., NLP International, Inc., Angioblast, Inc., and several other Columbia portfolio companies; and remains very active in the entrepreneurial and investment community, lecturing widely on the subjects of academic entrepreneurship and early stage investing. In 2008 he was named one of the "top 100 most influential New Yorkers in the digital business community" by Silicon Alley Insider. He serves on the Advisory Board of the National Council for Entrepreneurship and co-hosts its annual conference and business plan competition. He serves as a judge and mentor to Columbia Business School's Eugene Lang Entrepreneurial Initiative Fund and Greenhouse Programs and serves on the Advisory Board of the Columbia Venture Community. He is also a member of the Bar in Massachusetts, Pennsylvania, and the District of Columbia.
David Lerner Slides
_______________________
Paul Sciabica
(Executive Director, New York Angels)
Bio
Paul Sciabica is the Executive Director of the New York Angels, a consortium of early-stage investors focusing on technology, media and services companies. Prior to joining the NYA, he was an investment banker at Merrill Lynch where he managed a venture fund and was responsible for 50+ investments. His board seat duties included educational software, fabless semiconductors, Internet and telecommunications equipment companies. He has been a technologist/strategic planner for The Washington Post, The National Association of Securities Dealers and The Board of Governors of the Federal Reserve Bank. Paul holds a BA in Economics from Bloomsburg University.
Paul Sciabica Slides
_______________________
Matt McCooe
(Chart Venture Partners)
Bio
Matt joined CVP at its inception, coming from Columbia University Science and Technology Ventures (STV) where he managed a portfolio of spinout companies and the deployment of STV's highly profitable seed fund. During his tenure at Columbia, eleven portfolio companies went public or were acquired by publicly traded companies. Prior to Columbia, Matt led two startup operations, both of which reached revenues in excess of $125MM and were acquired. In 1998, Matt co-founded Eureka Networks, a communications and application software organization. Earlier in his career, he managed product development, sales and marketing, and new product roll-outs for two Fortune 500 companies, Becton Dickinson and MCI. As a national sales leader at MCI, he rose to become marketing manager, launching MCI's flagship voice and data products for Avantel, the company’s start-up joint venture in Latin America. At CVP, Matt focuses on early stage investments in communications, software and robotics. He represents CVP on the Board of RemoteReality, StackSafe and PacStar Communications. Matt earned an MBA from the Columbia University Graduate School of Business and a BA from Boston College. Matt serves on Columbia’s Private Equity and Venture Capital Advisory Board, and as an SBIR reviewer for the National Science Foundation.
_______________________
Shalom Leaf
(Law Offices of Shalom Leaf)
Bio
Mr. Leaf has represented major national research institutions for more than 15 years. He has also represented clients in the bioscience, Internet, software, computer hardware, media, apparel, real estate, beverage, venture capital and securities industries. He is a 1988 graduate of the New York University School of Law and has been a counsel at Herrick, Feinstein LLP and a partner at Squadron, Ellenoff, Plesent & Sheinfeld, LLP and Hogan & Hartson LLP. Mr. Leaf’s independent corporate and securities law practice focuses on the representation of: research and educational institutions in start-up, licensing and corporate matters; entrepreneurs, start-ups, joint ventures and established businesses in organizational, employment, financing, securities, M&A, “corporate strife” and intellectual property matters; and private equity investors and other financing sources in equity and debt transactions.
Shalom Leaf Slides
Among the topics to be covered:
- How recent market developments are affecting tech transfer offices and startups.
- Emerging trends in the angel investment market.
- Emerging trends in the venture investment market.
- Changes in legal terms of startup transactions.
- Positioning startups for funding and operational success.
COST: Free, but registration required. Long distance charges from your phone company may apply depending your phone plan.
HOW TO PARTICIPATE?: This webinar is online. You need a computer with web access for the visual and a regular phone line to hear the audio. Q&A is conducted by a chat box to the speakers.
WHO SHOULD PARTICIPATE IN THE WEBINAR?: This webinar is open to the public and anyone interested in the International Innovation Economy is invited to attend, including VCs and angel investors, investment professionals, economic development officers, university economic development officials, startup creation managers and professionals, entrepreneurial researchers and grad students, technology transfer managers and professionals, licensing specialists, business development officers, corporate strategic investors, entrepreneurs-in-residence, university research park managers, and others with an interest in the global innovation economy.
_______________________
David B. Lerner
(Director, New Ventures, Science and Technology Ventures, Columbia University)
Bio
David manages Columbia's portfolio of more than sixty spin-off companies, helps launch approximately ten to twelve new start-ups each year and administrates STV's Seed Fund. Prior to joining Columbia, he spent over a decade founding, operating, and funding companies in the healthcare, internet and media sectors. The venture group he founded has invested in medical devices, video platforms, security software, skill-based gaming and consumer internet. David spearheaded the commercialization of a medical therapy that became the state-of-the-art treatment for lymphedema, a debilitating condition that affects 1% of all Americans. He opened multiple treatment facilities and operated a nationally renowned teaching school, securing affiliations with Massachusetts General, Brigham and Women's Hospital, the Dana Farber Cancer Center, and Memorial Sloan-Kettering Cancer Center. After a strategic merger in 1998, the business was acquired in 2001 by one of the nation's leading providers of physical medicine and rehabilitation services. David's most recent venture was the founding and seed-funding of a video management platform company that secured $6 million in Series A funding and was sold to a publicly held company on the NASDAQ. He currently serves as Board Observer to StackSafe, Inc., NLP International, Inc., Angioblast, Inc., and several other Columbia portfolio companies; and remains very active in the entrepreneurial and investment community, lecturing widely on the subjects of academic entrepreneurship and early stage investing. In 2008 he was named one of the "top 100 most influential New Yorkers in the digital business community" by Silicon Alley Insider. He serves on the Advisory Board of the National Council for Entrepreneurship and co-hosts its annual conference and business plan competition. He serves as a judge and mentor to Columbia Business School's Eugene Lang Entrepreneurial Initiative Fund and Greenhouse Programs and serves on the Advisory Board of the Columbia Venture Community. He is also a member of the Bar in Massachusetts, Pennsylvania, and the District of Columbia.
David Lerner Slides
_______________________
Paul Sciabica
(Executive Director, New York Angels)
Bio
Paul Sciabica is the Executive Director of the New York Angels, a consortium of early-stage investors focusing on technology, media and services companies. Prior to joining the NYA, he was an investment banker at Merrill Lynch where he managed a venture fund and was responsible for 50+ investments. His board seat duties included educational software, fabless semiconductors, Internet and telecommunications equipment companies. He has been a technologist/strategic planner for The Washington Post, The National Association of Securities Dealers and The Board of Governors of the Federal Reserve Bank. Paul holds a BA in Economics from Bloomsburg University.
Paul Sciabica Slides
_______________________
Matt McCooe
(Chart Venture Partners)
Bio
Matt joined CVP at its inception, coming from Columbia University Science and Technology Ventures (STV) where he managed a portfolio of spinout companies and the deployment of STV's highly profitable seed fund. During his tenure at Columbia, eleven portfolio companies went public or were acquired by publicly traded companies. Prior to Columbia, Matt led two startup operations, both of which reached revenues in excess of $125MM and were acquired. In 1998, Matt co-founded Eureka Networks, a communications and application software organization. Earlier in his career, he managed product development, sales and marketing, and new product roll-outs for two Fortune 500 companies, Becton Dickinson and MCI. As a national sales leader at MCI, he rose to become marketing manager, launching MCI's flagship voice and data products for Avantel, the company’s start-up joint venture in Latin America. At CVP, Matt focuses on early stage investments in communications, software and robotics. He represents CVP on the Board of RemoteReality, StackSafe and PacStar Communications. Matt earned an MBA from the Columbia University Graduate School of Business and a BA from Boston College. Matt serves on Columbia’s Private Equity and Venture Capital Advisory Board, and as an SBIR reviewer for the National Science Foundation.
_______________________
Shalom Leaf
(Law Offices of Shalom Leaf)
Bio
Mr. Leaf has represented major national research institutions for more than 15 years. He has also represented clients in the bioscience, Internet, software, computer hardware, media, apparel, real estate, beverage, venture capital and securities industries. He is a 1988 graduate of the New York University School of Law and has been a counsel at Herrick, Feinstein LLP and a partner at Squadron, Ellenoff, Plesent & Sheinfeld, LLP and Hogan & Hartson LLP. Mr. Leaf’s independent corporate and securities law practice focuses on the representation of: research and educational institutions in start-up, licensing and corporate matters; entrepreneurs, start-ups, joint ventures and established businesses in organizational, employment, financing, securities, M&A, “corporate strife” and intellectual property matters; and private equity investors and other financing sources in equity and debt transactions.
Shalom Leaf Slides